116 related articles for article (PubMed ID: 3094803)
1. Detection of spread of malignant lymphoma to the liver by low field strength magnetic resonance imaging.
Richards MA; Webb JA; Reznek RH; Davies G; Jewell SE; Shand WS; Wrigley PF; Lister TA
Br Med J (Clin Res Ed); 1986 Nov; 293(6555):1126-8. PubMed ID: 3094803
[TBL] [Abstract][Full Text] [Related]
2. Detection of a systemic effect of malignancy in vivo by magnetic resonance imaging.
Richards MA; Gregory WM; Webb JA
Magn Reson Imaging; 1988; 6(5):557-65. PubMed ID: 3226239
[TBL] [Abstract][Full Text] [Related]
3. An attempt to characterize malignant lymphoma in spleen, liver and lymph nodes with magnetic resonance imaging.
Nyman R; Rhen S; Ericsson A; Glimelius B; Hagberg H; Hemmingsson A; Sundström C
Acta Radiol; 1987; 28(5):527-33. PubMed ID: 2960343
[TBL] [Abstract][Full Text] [Related]
4. Low field strength magnetic resonance imaging of the spleen: results from volunteers and patients with lymphoma.
Richards MA; Webb JA; Jewell SE; Stansfeld AG; Lister TA; Wrigley PF
Br J Cancer; 1988 Apr; 57(4):408-11. PubMed ID: 3390375
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging of hepatic lymphoma.
Weinreb JC; Brateman L; Maravilla KR
AJR Am J Roentgenol; 1984 Dec; 143(6):1211-4. PubMed ID: 6333792
[TBL] [Abstract][Full Text] [Related]
6. [Relaxation time measurements in the differential magnetic resonance tomographic diagnosis of liver tumors].
Steudel A; Harder T; Träber F; Dewes W; Schlolaut KH; Köster O
Rofo; 1989 Oct; 151(4):449-55. PubMed ID: 2554383
[TBL] [Abstract][Full Text] [Related]
7. Characterization of lymphadenopathy by magnetic resonance relaxation times: preliminary results.
Dooms GC; Hricak H; Moseley ME; Bottles K; Fisher M; Higgins CB
Radiology; 1985 Jun; 155(3):691-7. PubMed ID: 4001371
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of different magnetic resonance imaging sequences for detecting local tumor progression after radiofrequency ablation of hepatic malignancies.
Weiss J; Rempp H; Clasen S; Notohamiprodjo M; Keßler DE; Pereira PL; Blumenstock G; Nikolaou K; Hoffmann R
Eur J Radiol; 2017 Sep; 94():85-92. PubMed ID: 28655432
[TBL] [Abstract][Full Text] [Related]
9. Ferrite-enhanced MR imaging of hepatic lymphoma: an experimental study in rats.
Weissleder R; Stark DD; Compton CC; Wittenberg J; Ferrucci JT
AJR Am J Roentgenol; 1987 Dec; 149(6):1161-5. PubMed ID: 3318339
[TBL] [Abstract][Full Text] [Related]
10. [A case of primary hepatic malignant lymphoma diagnosed by needle biopsy under peritoneoscopic examination].
Yuasa K; Yamada S; Takagi H; Nakano H; Suga K; Kobayashi S; Kojima M; Joshita H; Takemura Y; Imai N
Nihon Naika Gakkai Zasshi; 1986 Nov; 75(11):1616-21. PubMed ID: 2950191
[No Abstract] [Full Text] [Related]
11. Proton spectroscopic imaging (Dixon method) of the liver: clinical utility.
Schertz LD; Lee JK; Heiken JP; Molina PL; Totty WG
Radiology; 1989 Nov; 173(2):401-5. PubMed ID: 2552499
[TBL] [Abstract][Full Text] [Related]
12. [A case of isolated hepatic malignant lymphoma representing characteristic findings on radiological imaging].
Yamamoto N; Nishie A; Yoshimitsu K; Irie H; Aibe H; Tajima T; Asayama Y; Matake K; Nakayama T; Kakihara D; Ohga S; Nakamura K; Honda H
Fukuoka Igaku Zasshi; 2003 Nov; 94(11):319-22. PubMed ID: 14752938
[TBL] [Abstract][Full Text] [Related]
13. Signal strength on a 0.15-T magnetic resonance imager.
Hardy PA; Bronskill MJ; Henkelman RM
Med Phys; 1985; 12(5):581-5. PubMed ID: 2995779
[TBL] [Abstract][Full Text] [Related]
14. Focal hepatic lesions: comparative MR imaging at 0.5 and 1.5 T.
Steinberg HV; Alarcon JJ; Bernardino ME
Radiology; 1990 Jan; 174(1):153-6. PubMed ID: 2152980
[TBL] [Abstract][Full Text] [Related]
15. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
16. Hepatic metastases studied with MR and CT.
Heiken JP; Lee JK; Glazer HS; Ling D
Radiology; 1985 Aug; 156(2):423-7. PubMed ID: 4011905
[TBL] [Abstract][Full Text] [Related]
17. Primary liver lymphoma with hypercalcemia: a case report.
Hsiao HH; Liu YC; Hsu JF; Huang CF; Yang SF; Lin SF
Kaohsiung J Med Sci; 2009 Mar; 25(3):141-4. PubMed ID: 19419919
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.
Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Staudenherz A; Senn D; Raderer M; Weber M; Simonitsch-Klupp I; Mayerhoefer ME
PLoS One; 2016; 11(10):e0164118. PubMed ID: 27723817
[TBL] [Abstract][Full Text] [Related]
19. Assessment of fast dynamic imaging and the use of Gd-EOB-DTPA for MR-guided liver interventions.
Fischbach F; Thormann M; Seidensticker M; Kropf S; Pech M; Ricke J
J Magn Reson Imaging; 2011 Oct; 34(4):874-9. PubMed ID: 21769983
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization.
Stark DD; Felder RC; Wittenberg J; Saini S; Butch RJ; White ME; Edelman RR; Mueller PR; Simeone JF; Cohen AM
AJR Am J Roentgenol; 1985 Aug; 145(2):213-22. PubMed ID: 2992250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]